What We're Reading: Page
Industry reads hand-picked by our editors
Jul 23, 2021
-
The New York Times
A.I. Predicts the Shapes of Molecules to Come
-
The Wall Street Journal
U.S. Vaccine Panel Signals Preliminary Support for Covid-19 Booster Shots
-
FierceBiotech
Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table
-
The Boston Globe
Another white male CEO at MassBio? The group has some explaining to do
Jul 22, 2021
-
Evaluate Vantage
The Delta for Covid-19 vaccine efficacy
-
The New York Times
Ken Frazier, the former Merck chief, is heading to venture capital
-
Reuters
Roche in talks with FDA on Alzheimer's candidate, says CEO
Jul 21, 2021
Jul 20, 2021
-
The New York Times
How an Unproven Alzheimer’s Drug Got Approved
-
The Wall Street Journal
Opioid Settlement of $26 Billion Between Drug Companies, States Expected This Week
-
FierceBiotech
Gilead hires Arcus CMO, puts him in charge of pact with biotech
-
STAT
States are sitting on millions of surplus Covid-19 vaccine doses
Jul 19, 2021
Jul 16, 2021
Jul 15, 2021
-
STAT
Woodcock: FDA may have misstepped before Alzheimer’s drug approval
-
Bloomberg
Moderna's Next Act Is Using mRNA vs. Flu, Zika, HIV, and Cancer
-
Axios
Dems hatch plan to pay for soft infrastructure with renegotiated drug prices
-
BioPharma Dive
A cancer drug startup banks new funds for NK cell therapy
Previous
